0001209191-11-042547.txt : 20110804 0001209191-11-042547.hdr.sgml : 20110804 20110804200804 ACCESSION NUMBER: 0001209191-11-042547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110802 FILED AS OF DATE: 20110804 DATE AS OF CHANGE: 20110804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOWE CHRISTOPHER P. CENTRAL INDEX KEY: 0001376260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34637 FILM NUMBER: 111011889 MAIL ADDRESS: STREET 1: HANSEN MEDICAL, INC. STREET 2: 380 N. BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc CENTRAL INDEX KEY: 0001316175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201852016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 856-5600 MAIL ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-08-02 0 0001316175 Anthera Pharmaceuticals Inc ANTH 0001376260 LOWE CHRISTOPHER P. C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 0 1 0 0 Chief Financial Officer & CBO Common Stock 2011-08-02 4 S 0 4700 7.2752 D 4937 I By spouse Common Stock 2011-08-02 4 S 0 300 7.9267 D 4637 I By spouse Common Stock 2011-08-03 4 S 0 14600 6.8789 D 51151 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2011. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.78 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2011. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.77 to $7.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions, and 1,606 shares acquired under the Issuer 2010 Employee Stock Purchase Plan on June 30, 2011. /s/ Bradley A. Bugdanowitz, by power of attorney 2011-08-04